Regardless of the severity of coronavirus disease 2019 (COVID-19), a high proportion of
patients struggle with persistent respiratory or systemic symptoms after recovery. This is …

Many drugs have been approved for clinical trials for the treatment of COVID-19 disease,
focusing on either antiviral or anti-inflammatory approaches. Combining antiviral and anti …

The instrumental role of CK2 in the SARS-CoV-2 infection has pointed out this protein
kinase as promising therapeutic target in COVID-19. Anti-SARS-CoV-2 activity has been …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in late
2019 has triggered an ongoing global pandemic whereby infection may result in a lethal …

The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 9.2 million …

The coronavirus disease (COVID-19) pandemic has highlighted the ability of scientists to
quickly react to the immense challenge presented to the world. The orally available 3CL …

The recent emergence of coronavirus disease-2019 (COVID-19) as a pandemic affecting
millions of individuals has raised great concern throughout the world, and the severe acute …

Neutrophil serine proteases cathepsin G (CG), neutrophil elastase (NE), and proteinase 3
(PR3) have recently been shown to contribute to killing of Streptococcus pneumoniae in …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for
coronavirus disease 2019 (COVID-19). Since its emergence, the COVID-19 pandemic has …

Abstract Zinc pyrithione (1a), together with its analogues 1b–h and ruthenium pyrithione
complex 2a, were synthesised and evaluated for the stability in biologically relevant media …